C679X loss-of-function PCSK9 variant lowers fasting glucose levels in a black South African population: A longitudinal study.
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2018.09.012
Abstract: AIMS To determine the longitudinal association of the loss-of-function (LOF) PCSK9 variants (C679X and A443T), proxies of PCSK9 inhibitor drugs, with LDL-C, fasting glucose and glycated hemoglobin. METHODS We conducted a five year, longitudinal study,… read more here.
Keywords: fasting glucose; loss function; pcsk9; c679x a443t ... See more keywords